Snowball logo
logo
BLRX_logo

BioLineRx Ltd

BLRX β€’ NASDAQ
$2.81+$0.05Β  (1.81%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
--4.828.941.189361.403211
COGS
0.7020.6543.6929.2630.7589730.354643
Gross Profit
(0.702)(0.654)1.10819.680.4303871.048568
Operating Expenses & Income
Operating Income
(24.78)(29.16)(49.69)(20.41)(10.37)(10.92)
Total Operating Expenses
24.7829.1650.840.0910.811.97
R&D Expenses
19.4717.6312.529.1497.6582749.013147
Selling General & Admin Expenses
4.2665.06616.6418.463.9162.729
Earnings from Continuing Operations
Interest Expense
(0.984)(2.158)(2.169)(9.16228)(1.290154)(1.111749)
Interest Income
0.5590.6942.0071.821.1241.112
Income Tax Expense
1.09(4.206)0.001---
Net Income
Net Income
(27.05)(24.95)(60.61)(9.221)(1.184321)(8.891635)
Supplemental
EBIT
(26.07)(22.79)(58.47)(0.147)(0.751918)(8.643218)
EBITDA
(25.37)(22.14)(57.09)3.918(0.22477)(8.196825)
In millions of USD, except % and values per 1 share